2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Parallel session 5 – Open mini-oral presentations Topic: Pancreas transplantation

5.9 - Efficacy of pancreas transplantation: impact on glycemic control, cardiovascular outcomes and survival

Presenter: Y., Kudva, Rochester, USA
Authors: Y. Kudva, A. Parsaik, M. Dong, N. Rostambeigi, W. Kremers, P. Dean, F. Cosio, M. Prieto, M. Stegall


Efficacy of pancreas transplantation: impact on glycemic control, cardiovascular outcomes and survival

Y. Kudva, A. Parsaik, M. Dong, N. Rostambeigi, W. Kremers, P. Dean, F. Cosio, M. Prieto, M. Stegall
Mayo Clinic, Rochester, MN, USA

Objective: To evaluate the efficacy of pancreas transplantation (PT) by measuring it’s impact on severe hypoglycemia (SH), diabetic ketoacidosis (DKA), glycemic control and cardiovascular outcomes.

Methods: 252 patients underwent PT ( simultaneous pancreas-kidney 60, pancreas alone 71, and pancreas after kidney transplants 121) at our institution between 01/01/1998 and 12/31/2009. PT was considered fully functional (FF) if normal C-peptide, HbA1c < 7%, FPG<126mg/dl, and not on any anti-hyperglycemic treatment (AHT); as partially functional (PF) if C-peptide was > 200 pmol/L, and on AHT; and as complete allograft failure (CF) if C-peptide < 200 pmol/L with AHT.

Results: Mean age was 43.9±9 years with 53% males. Median follow up was 6.3 (IQR 3-9) years. At last follow up 168 patients had FF graft, 48 PF, and 36 had CF. The cumulative incidence for PF is 12%, 17%, and 29% at 1, 2, and 5 years. The cumulative incidence for CF is 5%, 7%, and 14% at 1, 2, and 5 years. 8 patients experienced 10 episodes of DKA which differed according to graft failure status (p=0.003) (PF vs FF HR [Hazard Ratio] = 14.5, p=0.036; CF vs FF HR=66.4, p<0.001) after adjusting for age, gender, and transplant type. SH was experienced by 21 patients and differed between graft failure status groups (p<0.001) (PF vs FF HR=95.9, p<0.001; CF vs FF HR=257.3, p<0.001; CF vs PF HR=4.2, p=0.041) after covariate adjustment. Cardiovascular events (CV) occurred in 73 patients and were similar between groups (p=0.160) after covariate adjustment. Adjusted patient survival was different overall according to graft status (p<0.001), but the pair wise differences were only significant between CF and FF (CF vs FF HR=3.95, p<0.001; PF vs FF HR=1.99, p=0.058; CF vs PF HR=1.99, p=0.118).

Conclusion: Fully functioning pancreas allograft significantly decreases the risk of metabolic emergencies.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada